Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4968152 | 0.84 | CYP1A2 (0.62) | TAAR1AOC3TDP1ALOX5CYP1A2 | |
| SCHEMBL28929226 | 0.81 | SIGMAR1 (0.64) | ALOX5SIGMAR1 | |
| SCHEMBL28457555 | 0.81 | SIGMAR1 (0.64) | ALOX5SIGMAR1 | |
| SCHEMBL28422310 | 0.80 | TAAR1 (0.67) | TAAR1AOC3TDP1ALOX5CYP1A2 | |
| SCHEMBL9353620 | 0.78 | TAAR1 (0.52) | TAAR1AOC3TDP1ALOX5CYP1A2 | |
| SCHEMBL8606673 | 0.78 | CYP1A2 (0.79) | TAAR1AOC3TDP1ALOX5CYP1A2 | |
| SCHEMBL1344100 | 0.78 | OPRK1 (0.65) | TAAR1AOC3TDP1OPRK1ALDH1A1 | |
| SCHEMBL7075328 | 0.77 | AOC3 (0.59) | TAAR1AOC3TDP1ALOX5CYP1A2 | |
| SCHEMBL1520687 | 0.77 | ALOX5 (0.65) | TAAR1AOC3TDP1ALOX5CYP1A2 | |
| Hydrogen Peroxide SCHEMBL10839871 | 0.76 | TDP1 (0.71) | TAAR1TDP1ALDH1A1HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118923830-A | Honey dew added with food ingredients and production process thereof | 武汉安孕堂创新科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| EP-4206236-A1 | COMPOUNDS, THEIR SYNTHESIS AND COMPOSITIONS COMPRISING THE COMPOUNDS FOR ENHANCED DEPOSITION OF POLYMERS ONTO HAIR SURFACES | Kao Corporation (JP) | 2023-07-05 | — | — | EP | claimed |
| CN-116084019-A | Substituent regulation-based hybrid organic-inorganic perovskite crystal and synthesis method thereof | 南开大学 | 2023-05-09 | — | — | CN | claimed |
| CN-111146430-B | Porous core-shell structure silicon-carbon negative electrode material for lithium ion battery and preparation method thereof | 马鞍山科达普锐能源科技有限公司 | 2022-08-23 | — | — | CN | claimed |
| CN-111470822-A | Preparation method of concrete | 海娇 | 2020-07-31 | — | — | CN | claimed |
| WO-2019190402-A1 | BIOCOMPATIBLE OPHTHALMIC DEVICE | SINGAPORE HEALTH SERVICES PTE LTD (SG) | 2019-10-03 | — | — | WO | claimed |
| EP-2064251-B1 | BIOMIMETIC COMPOUNDS AND SYNTHETIC METHODS THEREFOR | KENSEY NASH CORP (US) | 2017-10-25 | — | — | EP | claimed |
| US-9115289-B2 | Multibranched bioadhesive compounds and synthetic methods therefor | KENSEY NASH CORPORATION (US) | 2015-08-25 | — | — | US | claimed |
| US-8907045-B2 | Biocompatible adhesive polymers | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-12-09 | — | — | US | claimed |
| US-20140041802-A1 | BIOCOMPATIBLE ADHESIVE POLYMERS | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-02-13 | — | — | US | claimed |
| EP-2348835-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | KNC NER Acquisition Sub, Inc. (US) | 2011-08-03 | — | — | EP | claimed |
| WO-2010091298-A1 | MULTIBRANCHED BIOADHESIVE COMPOUNDS AND SYNTHETIC METHODS THEREFOR | NERITES CORPORATION (US) | 2010-08-12 | — | — | WO | claimed |
| US-20100113828-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | NERITES CORPORATION (US) | 2010-05-06 | — | — | US | claimed |
| WO-2010037045-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | NERITES CORPORATION (US) | 2010-04-01 | — | — | WO | claimed |
| WO-2008154083-A2 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES | PROTEO TECH INC. (US) | 2008-12-18 | — | — | WO | claimed |
| US-5310539-A | Paramagnetic rare earth metals, magnetic resonance imaging | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-05-10 | — | — | US | claimed |
| EP-0580734-A1 | MELANIN-BASED AGENTS FOR IMAGE ENHANCEMENT | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-02-02 | — | — | EP | claimed |
| EP-0395529-B1 | Hydroxyphenethylamine derivative and its salts, method of preparation, medical application and use as specific pharmacological tool | ROUSSEL UCLAF (FR) | 1993-11-03 | — | — | EP | claimed |
| WO-1992018166-A1 | MELANIN-BASED AGENTS FOR IMAGE ENHANCEMENT | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0395529-A1 | Hydroxyphenethylamine derivative and its salts, method of preparation, medical application and use as specific pharmacological tool | ROUSSEL-UCLAF (FR) | 1990-10-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113828-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | COMT, HAAO, PNMT | TAAR1 2022/4885AOC3 127/4885TDP1 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.